Department of Nuclear Medicine, MIOT International.
Department of Medical Oncology, Apollo cancer hospitals.
Nucl Med Commun. 2022 Sep 1;43(9):1015-1025. doi: 10.1097/MNM.0000000000001596. Epub 2022 Aug 10.
The aim of this pilot study was to assess the role of dynamic whole-body PET and parametric imaging in the biological characterization of primary breast cancer.
In total 24 histologically proven primary breast cancer lesions in 21 consecutive patients were retrospectively analyzed. Each patient underwent 18F-fluoro-deoxyglucose whole-body dynamic PET-CT before any treatment. Dynamic PET images were acquired in the list mode for a total duration of 70 min. The reconstructed parametric imaging generated Patlak plot-based 'Slope' and 'Intercept' images, from which parametric indices ki and DV were obtained. The standard uptake value (SUV) metric was also obtained by summing the last few frames of the dynamic study. ki, distribution volume (DV) and SUV were correlated with the histological tumor grade, biomarkers [hormone receptors and human epidermal growth factor receptor 2 (HER-2) neu expression] and molecular subtypes (A, B and C) as well as with tumor size, regional nodal metastases and distant metastases.
The mean ki was found to be significantly higher in grade III than II lesions (P = 0.005), HER-2 neu positive status (P = 0.04) and molecular subtype B (P = 0.04) as well as in greater than T1 lesions(P = 0.0003 and P = 0.04, respectively) and node-positive lesions (P = 0.009). Though mean ki was not found to be significant for the hormone receptors status (P = 0.08), it showed the best correlation compared to the other parameters (P = 0.8 for DV and P = 0.1 for SUV). Spearman's correlation test, area under the curve (AUC) and mismatch percentage also revealed ki to predict tumor grade (AUC, 0.95; r = 0.7; P = 0.0001), HER-2 neu status and molecular subtypes (AUC, 0.81; r = 0.49 and P = 0.01) along with the hormone receptors status (AUC, 0.83; r = 0.32; P = 0.1). The mean DV failed to show any association with any of the biological or anatomical staging parameters. Though ki was found to be comparable to that of SUV in almost all the assessed parameters, it appeared to be better for predicting hormone receptors status even though both parameters were not statistically significant.
Our initial observation in a small cohort of breast cancer patients suggests that ki is promising in stratifying primary breast cancer lesions according to the tumor grade and biological characteristics.
本初步研究旨在评估全身动态 PET 和参数成像在原发性乳腺癌生物学特征中的作用。
共回顾性分析了 21 例连续患者的 24 例经组织学证实的原发性乳腺癌病变。每位患者在任何治疗前均接受 18F-氟脱氧葡萄糖全身动态 PET-CT 检查。动态 PET 图像以列表模式采集,总时长为 70 分钟。重建的参数成像生成基于 Patlak 图的“斜率”和“截距”图像,从中获得参数指数 ki 和分布容积(DV)。通过对动态研究的最后几帧进行求和还获得了标准摄取值(SUV)。ki、分布容积(DV)和 SUV 与组织学肿瘤分级、生物标志物[激素受体和人表皮生长因子受体 2(HER-2)neu 表达]和分子亚型(A、B 和 C)以及肿瘤大小、区域淋巴结转移和远处转移相关。
发现 III 级病变的平均 ki 值明显高于 II 级病变(P=0.005)、HER-2 neu 阳性状态(P=0.04)和分子亚型 B(P=0.04),以及大于 T1 病变(P=0.0003 和 P=0.04)和淋巴结阳性病变(P=0.009)。虽然 ki 值与激素受体状态不显著相关(P=0.08),但与其他参数相比,ki 值相关性最好(与 DV 的 P=0.8,与 SUV 的 P=0.1)。Spearman 相关检验、曲线下面积(AUC)和不匹配百分比也表明 ki 可预测肿瘤分级(AUC,0.95;r=0.7;P=0.0001)、HER-2 neu 状态和分子亚型(AUC,0.81;r=0.49 和 P=0.01)以及激素受体状态(AUC,0.83;r=0.32;P=0.1)。平均 DV 与任何生物学或解剖分期参数均无关联。虽然 ki 值在几乎所有评估的参数中都与 SUV 相当,但它在预测激素受体状态方面似乎更好,尽管这两个参数都没有统计学意义。
我们在小队列的乳腺癌患者中的初步观察表明,ki 在根据肿瘤分级和生物学特征对原发性乳腺癌病变进行分层方面很有前途。